Financials
- Market Capitalization 253.51 M
- Employee 78
- Founded 2018
- CEO N/A
- Website www.centurytx.com
- Headquarter Delaware, United States
- FIGI BBG00PM8N5W0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.11
ratio cours/chiffre d'affaires
0.79
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3371 | RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 2.32 USD | -6.45% | -7.94% | -29.48% | -40.82% | 254.68 M USD | ||
| 3373 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.82 USD | -1.62% | -9.90% | -22.22% | +15.19% | 253.96 M USD | ||
| 3385 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 3.12 USD | -4.29% | -13.33% | -36.46% | -72.75% | 250.14 M USD | ||
| 3395 | FATE Fate Therapeutics, Inc. - Common Stock | 2.05 USD | -3.76% | -14.23% | -10.87% | +48.55% | 245.63 M USD |